Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Ecol Evol ; 14(5): e11377, 2024 May.
Article in English | MEDLINE | ID: mdl-38756687

ABSTRACT

Behaviour change through voluntary action can be an important approach to reducing human impacts on biodiversity. One example is self-regulation in hunting, potentially a vital contributory factor in improving the sustainability of wild bird harvest. There has been a growing realisation among woodcock Scolopax rusticola hunters, reinforced by advice from sector organisations, that components of the UK woodcock populations are declining and that some aspects of woodcock hunting, specifically timing of harvest, may contribute to these. This study utilised five qualitative and quantitative data sets, collected for different purposes, to assess the behaviour and attitudes of woodcock hunters, both currently and over the past century. In the UK, relatively few woodcock are harvested and few hunters or species-specific shoots target them. An estimated 26%-29% of lowland shoots advertise or harvest woodcock, with fewer than 5% of shoots or hunters participating in 'woodcock specific' shoot days. The number of birds harvested has fallen in recent years and is estimated to be between 62,000 and 140,000. Qualitative data suggests that over 90% of hunters now report shooting woodcock only after the recommended date of 1st December, or not at all. This is reflected in bag data which shows that, since 2018, fewer than 3%-13% of woodcock shot were harvested prior to 1st December. Around a third of hunters have reported stopping shooting woodcock and it is likely the harvest will decline in coming years due to voluntary restraint. This work demonstrates both through self-report data and independent harvest data that behaviour change among hunters can be effected. This provides a working example where self-regulation in response to a collective sector-led effort has the potential to conserve wild quarry.

2.
Curr Transplant Rep ; 8(4): 324-332, 2021 Dec.
Article in English | MEDLINE | ID: mdl-36059891

ABSTRACT

Purpose of review: The purpose of this review is to describe the Southeastern Kidney Transplant Coalition's mission, vision, goals, and Early Transplant Access registry as an example of a community/academic collaboration dedicated to improving access to transplantation and reducing inequities in transplant access. Recent findings: The barriers and facilitators to referral and evaluation for kidney transplantation are not necessarily the same as for waitlisting and transplantation. Recent findings suggest that inequities in transplant access are multilevel and multifactorial and require continued community engagement to improve access to kidney transplantation across patients, health systems, and populations. Summary: Community-engaged approaches are critical to ensuring that inequities in transplant access - which may vary across regions -- are not only described but are addressed in practice in a sustainable manner.

3.
J Cyst Fibros ; 20(3): 499-505, 2021 05.
Article in English | MEDLINE | ID: mdl-33358691

ABSTRACT

BACKGROUND: The impact of lumacaftor/ivacaftor on exercise tolerance in people with cystic fibrosis (CF) has not been thoroughly studied. METHODS: We conducted a multisite Phase 4 trial comparing the impact of lumacaftor/ivacaftor on exercise tolerance with that of placebo in participants ≥ 12 years of age with CF homozygous for F508del-CFTR. The primary endpoint was relative change from baseline in maximum oxygen consumption (VO2max) during cardiopulmonary exercise testing (CPET) at Week 24. The key secondary endpoint was relative change from baseline in exercise duration during CPET at Week 24. Other secondary endpoints included changes in other indices of exercise tolerance and changes in CF assessments; safety and tolerability were assessed as an endpoint. RESULTS: Seventy participants were randomized to receive lumacaftor/ivacaftor (n = 34) or placebo (n = 36). The least-squares mean difference for lumacaftor/ivacaftor versus placebo in relative change in VO2max from baseline at Week 24 was -3.2% (95% CI: -9.2, 2.9; P=0.3021); the least-squares mean difference in relative change from baseline in exercise duration at Week 24 was -3.2% (95% CI: -8.0, 1.6). Safety results were consistent with the known lumacaftor/ivacaftor safety profile. CONCLUSIONS: Definitive conclusions regarding the impact of lumacaftor/ivacaftor on exercise tolerance cannot be drawn from these results; however, multicenter studies using CPETs can be reliably performed with multiple time points and conventional methods, provided that calibration can be achieved. Future studies of exercise tolerance may benefit from lessons learned from this study. NCT02875366.


Subject(s)
Aminophenols/therapeutic use , Aminopyridines/therapeutic use , Benzodioxoles/therapeutic use , Cystic Fibrosis/drug therapy , Cystic Fibrosis/physiopathology , Exercise Tolerance , Oxygen Consumption/physiology , Quinolones/therapeutic use , Adolescent , Adult , Child , Chloride Channel Agonists/therapeutic use , Double-Blind Method , Exercise Test , Female , Humans , Male
4.
J Appl Physiol (1985) ; 126(5): 1399-1408, 2019 05 01.
Article in English | MEDLINE | ID: mdl-30702975

ABSTRACT

Derecruitment of air spaces in the lung occurs when airways close during exhalation and is related to ventilation heterogeneity and symptoms in asthma. The forced oscillation technique has been used to identify surrogate measures of airway closure via the reactance (Xrs) versus lung volume relationship. This study used a new algorithm to identify derecruitment from the Xrs versus lung volume relationship from a slow vital capacity maneuver. We aimed to compare two derecruitment markers on the Xrs versus volume curve, the onset reduction of Xrs (DR1vol) and the onset of more rapid reduction of Xrs (DR2vol), between control and asthmatic subjects. We hypothesized that the onset of DR1vol and DR2vol occurred at higher lung volume in asthmatic subjects. DR1vol and DR2vol were measured in 18 subjects with asthma and 18 healthy controls, and their relationships with age and height were examined using linear regression. In the control group, DR1vol and DR2vol increased with age (r2 = 0.68, P < 0.001 and r2 = 0.71, P < 0.001, respectively). DR1vol and DR2vol in subjects with asthma [76.58% of total lung capacity (TLC) and 56.79%TLC, respectively] were at higher lung volume compared with control subjects (46.1 and 37.69%TLC, respectively) (P < 0.001). DR2vol correlated with predicted values of closing capacity (r = 0.94, P < 0.001). This study demonstrates that derecruitment occurs at two points along the Xrs-volume relationship. Both derecruitment points occurred at significantly higher lung volumes in subjects with asthma compared with healthy control subjects. This technique offers a novel way to measure the effects of changes in airways/lung mechanics. NEW & NOTEWORTHY This study demonstrates that the forced oscillation technique can be used to identify two lung volume points where lung derecruitment occurs: 1) where derecruitment is initiated and 2) where onset of rapid derecruitment commences. Measurements of derecruitment increase with age. The onset of rapid derecruitment was highly correlated with predicted closing capacity. Also, the initiation and rate of derecruitment are significantly altered in subjects with asthma.


Subject(s)
Airway Resistance/physiology , Asthma/physiopathology , Lung/physiopathology , Bronchial Provocation Tests/methods , Female , Forced Expiratory Volume/physiology , Humans , Male , Middle Aged , Respiration , Spirometry/methods , Total Lung Capacity/physiology
SELECTION OF CITATIONS
SEARCH DETAIL